Filtros : "Matuoka, Jessica Yumi" "SECOLI, SILVIA REGINA" Limpar

Filtros



Refine with date range


  • Source: The European Journal of Health Economics. Unidade: EE

    Subjects: CUSTOS DOS CUIDADOS DE SAÚDE, ECONOMIA DA SAÚDE, NEOPLASIAS, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MATUOKA, Jessica Yumi e KAHN, James G e SECOLI, Silvia Regina. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. The European Journal of Health Economics, v. 20, n. Ju 2019, p. 487-499, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10198-018-1011-1. Acesso em: 02 nov. 2024.
    • APA

      Matuoka, J. Y., Kahn, J. G., & Secoli, S. R. (2019). Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. The European Journal of Health Economics, 20( Ju 2019), 487-499. doi:10.1007/s10198-018-1011-1
    • NLM

      Matuoka JY, Kahn JG, Secoli SR. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review [Internet]. The European Journal of Health Economics. 2019 ; 20( Ju 2019): 487-499.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10198-018-1011-1
    • Vancouver

      Matuoka JY, Kahn JG, Secoli SR. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review [Internet]. The European Journal of Health Economics. 2019 ; 20( Ju 2019): 487-499.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10198-018-1011-1
  • Source: JBI Database of Systematic Reviews and Implementation Reports. Unidade: EE

    Subjects: CUSTOS DOS CUIDADOS DE SAÚDE, INFECÇÕES BACTERIANAS, REVISÃO SISTEMÁTICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, Wendel Mombaque dos et al. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence. JBI Database of Systematic Reviews and Implementation Reports, v. 17, n. 12, p. 2417-2451, 2019Tradução . . Disponível em: https://doi.org/10.11124/JBISRIR-D-18-00019. Acesso em: 02 nov. 2024.
    • APA

      Santos, W. M. dos, Aromataris, E., Secoli, S. R., & Matuoka, J. Y. (2019). Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence. JBI Database of Systematic Reviews and Implementation Reports, 17( 12), 2417-2451. doi:10.11124/JBISRIR-D-18-00019
    • NLM

      Santos WM dos, Aromataris E, Secoli SR, Matuoka JY. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2019 ; 17( 12): 2417-2451.[citado 2024 nov. 02 ] Available from: https://doi.org/10.11124/JBISRIR-D-18-00019
    • Vancouver

      Santos WM dos, Aromataris E, Secoli SR, Matuoka JY. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2019 ; 17( 12): 2417-2451.[citado 2024 nov. 02 ] Available from: https://doi.org/10.11124/JBISRIR-D-18-00019
  • Source: JBI Database of Systematic Reviews and Implementation Reports. Unidade: EE

    Subjects: EFETIVIDADE, CUSTOS DOS CUIDADOS DE SAÚDE

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, Wendel Mombaque dos e MATUOKA, Jessica Yumi e SECOLI, Silvia Regina. Cost-effectiveness of the antimicrobial treatment for inpatients infected with Klebsiella pneumoniae carbapenemase: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, v. 16, n. 2, p. 336-344, 2018Tradução . . Disponível em: https://doi.org/10.11124/JBISRIR-2016-003332. Acesso em: 02 nov. 2024.
    • APA

      Santos, W. M. dos, Matuoka, J. Y., & Secoli, S. R. (2018). Cost-effectiveness of the antimicrobial treatment for inpatients infected with Klebsiella pneumoniae carbapenemase: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 16( 2), 336-344. doi:10.11124/JBISRIR-2016-003332
    • NLM

      Santos WM dos, Matuoka JY, Secoli SR. Cost-effectiveness of the antimicrobial treatment for inpatients infected with Klebsiella pneumoniae carbapenemase: a systematic review protocol [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2018 ; 16( 2): 336-344.[citado 2024 nov. 02 ] Available from: https://doi.org/10.11124/JBISRIR-2016-003332
    • Vancouver

      Santos WM dos, Matuoka JY, Secoli SR. Cost-effectiveness of the antimicrobial treatment for inpatients infected with Klebsiella pneumoniae carbapenemase: a systematic review protocol [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2018 ; 16( 2): 336-344.[citado 2024 nov. 02 ] Available from: https://doi.org/10.11124/JBISRIR-2016-003332

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024